Dr. Juliane Nguyen is Professor and Vice Chair in the Division of Pharmacoengineering and Molecular Pharmaceutics at the University of North Carolina at Chapel Hill and Founding Director of the C3 Drug Delivery CTSA Predoctoral Training Program. Her interdisciplinary research integrates molecular engineering and pharmaceutical sciences to develop personalized biotherapeutics for myocardial infarction, wound healing, colitis, cancer, and other diseases. She has overseen a research portfolio totaling more than $24 million, and her work has been published in Nature Biotechnology, Nature Communications, Nature Reviews Bioengineering, Advanced Functional Materials, Advanced Drug Delivery Reviews, and other leading journals.
Dr. Nguyen is a Fellow of the American Association of Pharmaceutical Scientists (AAPS), the American Institute for Medical and Biological Engineering (AIMBE), and the Controlled Release Society (CRS). Her honors include the 2026 CRS Samyang Award for outstanding innovation and contributions to drug delivery, the NSF CAREER Award, the AAPS Emerging Leader Award, and the BMES-CMBE Young Innovator Award. She was elected by the CRS membership to serve as Director-at-Large from 2026–2029.
Dr. Nguyen is Executive Editor of Advanced Drug Delivery Reviews, Associate Editor of Cellular and Molecular Bioengineering, and serves on the Editorial Board of the Journal of Controlled Release. She previously served on the NIH Drug and Biologic Therapeutic Delivery study section. Deeply committed to mentorship, she has advised more than 90 postdoctoral fellows, PhD students, and undergraduate researchers and founded the Future Leaders Launchpad to prepare emerging scientists for leadership careers in academia and industry.